Picture of Precision Biosciences logo

DTIL — Precision Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Precision Biosciences Presents Preclinical Data Highlighting Capabilities Of Arcus For Gene Insertion

Oct 26 (Reuters) - Precision BioSciences Inc  DTIL.O :
    * PRECISION BIOSCIENCES PRESENTS PRECLINICAL DATA
HIGHLIGHTING
CAPABILITIES OF ARCUS FOR GENE INSERTION AND EXCISION AT THE
EUROPEAN SOCIETY OF GENE & CELL THERAPY (ESGCT) 30TH ANNUAL
CONGRESS
    * PRECISION BIOSCIENCES INC - ARCUS SHOWED DURABLE,
HIGH-EFFICIENCY GENE INSERTION CAPABILITIES IN NHPS AND
COMPARISON TO CRISPR-CAS9
    * PRECISION BIOSCIENCES- DATA SHOWS ARCUS' ABILITY TO
ACHIEVE
LARGE GENE EXCISIONS ENABLING SIGNIFICANT FUNCTIONAL MUSCLE
IMPROVEMENT IN A DMD MOUSE MODEL

Source text for Eikon:  ID:nBw8JKWBqa 
Further company coverage:  DTIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Precision Biosciences

See all news